Price Alert

Biora Therapeutics Inc. (PROG)

NASDAQ: PROG · Real-Time Price · USD

0.88

-0.04 (-3.96%)

At close: May 09, 2022, 6:00 AM

Biora Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net Income	-228.96M	-247.41M	-230.07M	-233.39M	-207.64M
Depreciation & Amortization	510K	1.44M	2.36M	3.52M	4.61M
Stock-Based Compensation	11.38M	11.96M	11.77M	11.21M	11.24M
Other Working Capital	-17.99M	-16.32M	-27.88M	-24.53M	-70.77M
Other Non-Cash Items	102.02M	92.39M	48.6M	43.12M	45.51M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-27.84M	-25.86M	-30.17M	-30.06M	-37.14M
Operating Cash Flow	-142.88M	-167.49M	-197.5M	-205.59M	-183.42M
Capital Expenditures	-734K	-855K	-2.69M	-4.17M	-4.31M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-598K	-168K	n/a
Investing Cash Flow	-734K	-855K	-3.29M	-4.34M	-4.31M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	147.74M	166.83M	195.46M	162.86M	241.37M
Financial Cash Flow	147.74M	166.83M	195.46M	162.86M	241.37M
Net Cash Flow	1.96M	-3.68M	-5.88M	-47.62M	53.63M
Free Cash Flow	-143.61M	-168.34M	-200.19M	-209.76M	-187.74M